4//SEC Filing
Fawaz Ali D. 4
Accession 0001209191-22-029441
CIK 0001863127other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 8:38 PM ET
Size
9.9 KB
Accession
0001209191-22-029441
Insider Transaction Report
Form 4
Fawaz Ali D.
General Counsel and Secretary
Transactions
- Award
Stock Option (Right to Buy)
2022-05-16+2,301→ 2,301 totalExercise: $7.68Exp: 2032-05-15→ Common Stock (2,301 underlying) - Award
Stock Option (Right to Buy)
2022-05-16+3,752→ 3,752 totalExercise: $7.68Exp: 2032-05-15→ Common Stock (3,752 underlying) - Award
Stock Option (Right to Buy)
2022-05-16+361,586→ 361,586 totalExercise: $7.68Exp: 2032-05-15→ Common Stock (361,586 underlying)
Footnotes (2)
- [F1]The option vests based on achievement of a performance objective.
- [F2]25% of the shares subject to the option shall vest on May 16, 2023, and 1/36th of the remaining number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
Documents
Issuer
Tyra Biosciences, Inc.
CIK 0001863127
Entity typeother
Related Parties
1- filerCIK 0001928287
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 8:38 PM ET
- Size
- 9.9 KB